{"schema":"hottub-news/list/v1","item_schema":"hottub-news/item/v1","count":4,"sponsored":0,"items":[{"id":"n_hpb6nmbrfwrvmbs36dqq","seq":1343302,"kind":"article","title":"Teva Pharmaceutical Industries Ltd: Teva Presents New Efficacy and Safety Data with Ecopipam, an Investigational Treatment for Pediatric Patients with Tourette Syndrome","url":"https://www.finanznachrichten.de/nachrichten-2026-10/69742052-teva-pharmaceutical-industries-ltd-teva-presents-new-efficacy-and-safety-data-with-ecopipam-an-investigational-treatment-for-pediatric-patients-with-399.htm","published":"2026-10-02T12:41:46Z","seen":"2026-10-02T12:41:46Z","lang":"en","country":"DE","source":{"id":"finanznachrichten.de","name":"finanznachrichten.de","domain":"finanznachrichten.de","outlet":{"wikidata":"Q1408247","name":"Finanznachrichten.de","type":"website","designations":["website"]}},"via":"gdelt-gkg-english","topics":["health","economy","politics","business"],"authors":["GlobeNewswire (Europe)"],"entities":[{"id":"Q132104170","name":"Teva Pharmaceutical Industries Ltd","type":"org"},{"id":"Q5333851","name":"ecopipam","type":"other"}],"story":"st_k4byroqrg4osoopop5la","category":"health","category_p":0.8,"sentiment":"positive","tone":-0.13,"political":0.01},{"id":"n_e3fwbkvahfos6mdducja","seq":1343431,"kind":"article","title":"Teva Presents New Efficacy and Safety Data with Ecopipam, an Investigational Treatment for Pediatric Patients with Tourette Syndrome","url":"https://www.standard-freeholder.com/press-releases/globe-newswire/teva-presents-new-efficacy-and-safety-data-with-ecopipam-an-investigational-treatment-for-pediatric-patients-with-tourette-syndrome","published":"2026-10-02T12:06:00Z","seen":"2026-10-02T12:41:46Z","lang":"en","source":{"id":"standard-freeholder.com","name":"standard-freeholder.com","domain":"standard-freeholder.com"},"via":"gdelt-gkg-english","topics":["economy","health","politics","business"],"authors":["GlobeNewswire"],"entities":[{"id":"Q2868194","name":"World Esperantist Vegetarian Association","type":"org"},{"id":"Q5333851","name":"ecopipam","type":"other"},{"id":"Q191779","name":"Tourette syndrome","type":"other"}],"story":"st_k4byroqrg4osoopop5la","category":"health","category_p":0.79,"sentiment":"positive","tone":-0.13,"political":0.02},{"id":"n_ca2u7x5wjvygxwdceaxq","seq":1343141,"kind":"article","title":"Journal of Child Neurology Publishes Review Highlighting Dopamine's Role in Tourette Syndrome and Ecopipam's Selective D1 Receptor Mechanism for Tourette Syndrome in Pediatric Patients","url":"https://www.standard-freeholder.com/press-releases/globe-newswire/journal-of-child-neurology-publishes-review-highlighting-dopamines-role-in-tourette-syndrome-and-ecopipams-selective-d1-receptor-mechanism-for-tourette-syndrome-in-pediatric-patients","published":"2026-10-02T12:05:00Z","seen":"2026-10-02T12:41:46Z","lang":"en","source":{"id":"standard-freeholder.com","name":"standard-freeholder.com","domain":"standard-freeholder.com"},"via":"gdelt-gkg-english","topics":["economy","health","education","business"],"authors":["GlobeNewswire"],"entities":[{"id":"Q6294935","name":"Journal of Child Neurology","type":"org"},{"id":"Q170304","name":"dopamine","type":"other"},{"id":"Q191779","name":"Tourette syndrome","type":"other"},{"id":"Q5333851","name":"ecopipam","type":"other"}],"story":"st_xhpclwddgl4mtbg35yqa","category":"health","category_p":0.87,"sentiment":"neutral","tone":-0.32,"political":0.01},{"id":"n_xhpclwddgl4mtbg35yqa","seq":1335458,"kind":"press_release","title":"Journal of Child Neurology Publishes Review Highlighting Dopamine’s Role in Tourette Syndrome and Ecopipam’s Selective D1 Receptor Mechanism for Tourette Syndrome in Pediatric Patients","url":"https://www.globenewswire.com/news-release/2026/10/02/3373764/0/en/journal-of-child-neurology-publishes-review-highlighting-dopamine-s-role-in-tourette-syndrome-and-ecopipam-s-selective-d1-receptor-mechanism-for-tourette-syndrome-in-pediatric-pati.html","summary":"PARSIPPANY, N.J., Oct. 02, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced that the Journal of Child Neurology published a comprehensive review examining dopamine pathways in Tourette syndrome and the therapeutic potential of ecopipam, a first-in-class investigational selective D1 (dopamine) receptor antagonist for the treatment of pediatric patients with Tourette syndrome. 1,2 The…","published":"2026-10-02T12:00:00Z","seen":"2026-10-02T12:03:00Z","lang":"en","source":{"id":"globenewswire-public","name":"GlobeNewswire — public companies","domain":"globenewswire.com","outlet":{"wikidata":"Q5570956","name":"GlobeNewswire","type":"other","country":"US","designations":["business","press release distributor"]}},"via":"globenewswire-public","topics":["business","nyse:teva","tase:teva","tase:teva.ta","us8816242098","il0006290147"],"entities":[{"id":"Q5333851","name":"ecopipam","type":"other"}],"mentions":2,"story":"st_xhpclwddgl4mtbg35yqa","category":"health","category_p":0.87,"sentiment":"neutral","tone":0.3,"political":0.01}]}